TD Asset Management’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-6,581
| Closed | -$329K | – | 1555 |
|
|
2021
Q2 | $329K | Sell |
6,581
-2,100
| -24% | -$105K | ﹤0.01% | 1436 |
|
|
2021
Q1 | $582K | Hold |
8,681
| – | – | ﹤0.01% | 1374 |
|
|
2020
Q4 | $525K | Buy |
8,681
+532
| +7% | +$32.2K | ﹤0.01% | 1324 |
|
|
2020
Q3 | $644K | Hold |
8,149
| – | – | ﹤0.01% | 1188 |
|
|
2020
Q2 | $509K | Buy |
8,149
+550
| +7% | +$34.4K | ﹤0.01% | 1210 |
|
|
2020
Q1 | $403K | Hold |
7,599
| – | – | ﹤0.01% | 1216 |
|
|
2019
Q4 | $920K | Buy |
7,599
+1,532
| +25% | +$185K | ﹤0.01% | 1114 |
|
|
2019
Q3 | $1.1M | Sell |
6,067
-600
| -9% | -$109K | ﹤0.01% | 1036 |
|
|
2019
Q2 | $867K | Sell |
6,667
-354
| -5% | -$46K | ﹤0.01% | 1076 |
|
|
2019
Q1 | $1.71M | Sell |
7,021
-428
| -6% | -$104K | ﹤0.01% | 934 |
|
|
2018
Q4 | $1.42M | Sell |
7,449
-2,714
| -27% | -$517K | ﹤0.01% | 992 |
|
|
2018
Q3 | $3.33M | Buy |
10,163
+1,611
| +19% | +$528K | ﹤0.01% | 856 |
|
|
2018
Q2 | $2.67M | Buy |
8,552
+1,694
| +25% | +$528K | ﹤0.01% | 882 |
|
|
2018
Q1 | $1.67M | Buy |
6,858
+324
| +5% | +$78.9K | ﹤0.01% | 928 |
|
|
2017
Q4 | $1.97M | Buy |
6,534
+605
| +10% | +$183K | ﹤0.01% | 889 |
|
|
2017
Q3 | $1.57M | Sell |
5,929
-2,626
| -31% | -$694K | ﹤0.01% | 932 |
|
|
2017
Q2 | $2.25M | Sell |
8,555
-2,403
| -22% | -$633K | ﹤0.01% | 848 |
|
|
2017
Q1 | $3.95M | Buy |
10,958
+444
| +4% | +$160K | 0.01% | 742 |
|
|
2016
Q4 | $3.03M | Sell |
10,514
-512
| -5% | -$148K | 0.01% | 776 |
|
|
2016
Q3 | $3.75M | Buy |
11,026
+368
| +3% | +$125K | 0.01% | 758 |
|
|
2016
Q2 | $4.53M | Buy |
10,658
+32
| +0.3% | +$13.6K | 0.01% | 708 |
|
|
2016
Q1 | $3.4M | Buy |
10,626
+5,116
| +93% | +$1.64M | 0.01% | 756 |
|
|
2015
Q4 | $2.86M | Buy |
5,510
+1,070
| +24% | +$555K | 0.01% | 778 |
|
|
2015
Q3 | $1.3M | Buy |
4,440
+1,146
| +35% | +$336K | ﹤0.01% | 880 |
|
|
2015
Q2 | $1.3M | Buy |
3,294
+108
| +3% | +$42.5K | ﹤0.01% | 919 |
|
|
2015
Q1 | $964K | Buy |
+3,186
| New | +$964K | ﹤0.01% | 953 |
|